Berns on Nephrology

 
 
  • Can BP Go Too Low in Kidney Disease Patients?   Dr. Jeffrey Berns talks with Dr. Ray Townsend about a new study that found higher mortality in kidney disease patients whose systolic blood pressure dropped below 120 mm Hg.
  • 'We Can Do Better' With CKD and ESRD Patients   As he takes the reins as President of the National Kidney Foundation, Dr. Jeffrey Berns outlines ways to improve care in patients with chronic kidney disease and end-stage renal disease.
  • Risks to Live Kidney Donors: What to Tell Patients   New studies have raised serious questions about the risks faced by living kidney donors. Drs. Jeffrey Berns and Peter Reese tease out the issues to offer some guidance for clinicians.
  • Ask Patients About Recovery Time Post-dialysis   Dr. Jeffrey Berns reviews a new study that suggests clinicians can help dialysis patients by trying to reduce their recovery time after dialysis sessions.
  • Statin Reduces Risk for Contrast-Induced AKI   Dr. Jeffrey Berns advises clinicians to prescribe a statin to patients before they undergo coronary angiography, to reduce the risk for acute kidney injury from the contrast media.
  • Considerations in Predialysis Anemia Treatment   Are clinicians so focused on good outcomes that they overlook quality of life in some predialysis patients? Dr. Jeffrey Berns reviews a new study on the topic.
  • Offering Options for Dialysis: 'We Need to Do a Better Job'   Clinicians need to better educate themselves so that they are comfortable encouraging patients to try home dialysis and peritoneal dialysis, says Dr. Jeffrey Berns.
  • Keys to a Successful Home Dialysis Program   Dr. Joel Glickman talks with Dr. Jeffrey Berns about the benefits and potential barriers to establishing a home dialysis program.
  • Drinking Water: What's the Science?   Who should drink how much water? Bottled or tap? Dr. Jeffrey Berns and Dr. Stanley Goldfarb discuss the evidence and what you should tell patients.
  • Two Easy Steps Improve CKD Care   Dr. Jeffrey Berns reviews 2 recent studies that achieved significant improvements in the management of chronic kidney disease.
  • Hyponatremia: Don't Miss Subtle Clinical Clues   New guidelines suggest that asymptomatic hyponatremia doesn't really exist but that clinicians can identify and treat it if they know the warning signs. Dr. Jeffrey Berns discusses.
  • Paying Living Donors: Could a Trial Clarify the Issues?   Dr. Jeffrey Berns talks with Dr. Peter Reese about the benefits of conducting a trial with paid kidney donors to help sort out the ethical issues involved.
  • Warn Patients of Fall Risk Tied to BP Drugs   Dr. Jeffrey Berns reminds clinicians that antihypertension drugs may increase patients' risk for falls, especially if they are taking more than 1 such medication.
  • Postpone Dialysis Until Symptoms Occur   Dr. Jeffrey Berns reviews new guidelines from the Canadian Society of Nephrology that encourage clinicians to wait for patient symptoms before starting dialysis
  • Paying for Kidneys: A Good Idea?   Dr. Jeffrey Berns reflects on recent articles that discuss the merits and pitfalls of offering cash to potential kidney donors.
  • Renal Denervation, R.I.P.?   Dr. Jeffrey Berns discusses the implications of halting SYMPLICITY HTN-3, a study that was testing catheter-based renal denervation for the treatment of resistant hypertension.
  • Mortality Rates at Dialysis Centers: What Matters?   Dr. Jeffrey Berns reviews a study that compares mortality rates at for-profit dialysis facilities vs at nonprofit ones, reminding physicians that they are ultimately responsible for patients' care
  • What Does 'No Evidence' Really Mean?   What should clinicians do when 'there is no evidence to suggest' a certain treatment path? Dr. Jeffrey Berns reflects on a recent column in JAMA.
  • ACE + ARB = Adverse Events   If you have any patients on both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker, you probably should discontinue one of those medications, says Dr. Jeffrey Berns.
  • The Future of Nephrology   'We need to be truly expert' in managing chronic kidney disease, says Dr. Jeffrey Berns, in order to preserve the specialty of nephrology.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.